Kobo Biotech Ltd Stock Price Today (NSE: KOBO)
Fundamental Score
Kobo Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Kobo Biotech Ltd share price today is ₹4.33, up +4.84% on NSE/BSE as of 19 June 2026. Kobo Biotech Ltd (KOBO) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of ₹6.39 (Cr). The 52-week high for KOBO share price is ₹4.33 and the 52-week low is ₹1.99.
Kobo Biotech Ltd Share Price Chart — NSE/BSE Historical Performance
Kobo Biotech Ltd share price chart: 31.93% return over the past month. 52-week high ₹4.33, 52-week low ₹1.99.
Kobo Biotech Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹4.33 | ₹4.33 | ₹4.33 | ₹4.33 | 24.53K (Cr) | |
| ₹4.13 | ₹4.13 | ₹4.13 | ₹4.13 | 39.53K (Cr) | |
| ₹3.94 | ₹3.94 | ₹3.94 | ₹3.94 | 23.60K (Cr) | |
| ₹3.76 | ₹3.76 | ₹3.76 | ₹3.76 | 13.79K (Cr) | |
| ₹3.59 | ₹3.59 | ₹3.59 | ₹3.59 | 7.19K (Cr) | |
| ₹3.42 | ₹3.42 | ₹3.42 | ₹3.42 | 10.61K (Cr) | |
| ₹3.26 | ₹3.26 | ₹3.26 | ₹3.26 | 7.19K (Cr) | |
| ₹3.11 | ₹3.11 | ₹3.11 | ₹3.11 | 13.87K (Cr) | |
| ₹2.97 | ₹2.97 | ₹2.97 | ₹2.97 | 15.70K (Cr) | |
| ₹2.83 | ₹2.83 | ₹2.83 | ₹2.83 | 7.08K (Cr) |
Kobo Biotech Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹4.13 | ₹4.33 | ₹4.13 | ₹4.33 | +4.84% | |
| ₹2.71 | ₹3.94 | ₹2.58 | ₹3.94 | +45.39% | |
| ₹2.27 | ₹3.01 | ₹2.24 | ₹2.85 | +25.55% | |
| ₹2.50 | ₹2.62 | ₹2.17 | ₹2.23 | -10.80% | |
| ₹2.88 | ₹3.19 | ₹2.50 | ₹2.51 | -12.85% | |
| ₹2.50 | ₹2.64 | ₹2.06 | ₹2.62 | +4.80% | |
| ₹2.76 | ₹2.76 | ₹1.99 | ₹2.39 | -13.41% | |
| ₹3.27 | ₹3.27 | ₹2.82 | ₹2.82 | -13.76% | |
| ₹2.39 | ₹3.58 | ₹2.20 | ₹3.44 | +43.93% | |
| ₹2.25 | ₹2.46 | ₹2.08 | ₹2.40 | +6.67% | |
| ₹2.43 | ₹2.65 | ₹2.20 | ₹2.35 | -3.29% | |
| ₹2.54 | ₹2.90 | ₹2.31 | ₹2.43 | -4.33% |
AI Research Briefing
Powered by Gemini · 2026-04-10
This microcap commodity chemical company in CIRP is a value trap with significant downside risk.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Kobo Biotech's share price was The stock's 52-week range is to The company is undergoing Corporate Insolvency Resolution Process (CIRP).
CORE STORY (THE REAL GAME)
This is not a turnaround story; it's a potential value trap in a commodity chemical microcap. Market likely pricing in a distressed asset play with hopes of restructuring or acquisition.
- Micro-cap speculation
- CIRP hopes
- Successful debt restructuring
- Acquisition by a larger player
- Negative news on CIRP
- Micro/SME cap - illiquidity risk
- Ongoing Corporate Insolvency Resolution Process (CIRP)
- Negative ROCE of -52.9%
No FII/DII interest. Promoter holding steady at 44.95%.
Indian chemical production projected to increase by 10.9% in 2026, but Kobo's financials are a major headwind.
Free Cash Flow 5Y: ₹124.71 Cr, but recent profitability is weak.
CIRP outcome will determine the future. Without successful restructuring, the company faces liquidation.
Primary Thesis Risk
Failure of CIRP leading to liquidation.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Kobo Biotech Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Kobo Biotech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KOBO across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Strong Cash Generation (₹124.71 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Suboptimal ROCE (-52.90%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Kobo Biotech Ltd vs Commodity Chemicals Peers
Peer Comparison - Commodity Chemicals
Compare Kobo Biotech Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Kobo Biotech LtdKobo Biotech Lt...Selected✓ KOBO • 531541 | 20.3/100 | ₹4.33₹4 | ₹6.39₹6.39 | — — | — — | -52.90%Poor -52.90% Poor | — — | 12.21%Good 12.21% Good | — — | 0.00% |
SRF LtdSRF Ltd... SRF • 503806 | 49.8/100 | ₹2736.80₹2737 | ₹86606.52₹86606.52 | 53.54Average 53.5 Average | 10.37%Average 10.37% Average | 12.27%Average 12.27% Average | 0.35Excellent 0.3 Excellent | 4.40%Average 4.40% Average | 15.30%Excellent 15.30% Excellent | 0.25% |
Tata Chemicals LtdTata Chemicals ... TATACHEM • 500770 | 14.9/100 | ₹774.55₹775 | ₹20261.08₹20261.08 | 62.18Average 62.2 Average | 1.20%Poor 1.20% Poor | 3.96%Poor 3.96% Poor | 0.34Excellent 0.3 Excellent | -47.92%Poor -47.92% Poor | 7.53%Good 7.53% Good | 1.38% |
Deepak Fertilisers and Petrochemicals Corporation LtdDeepak Fertilis... DEEPAKFERT • 500645 | 57/100 | ₹1448.30₹1448 | ₹17120.52₹17120.52 | 17.39Average 17.4 Average | 15.56%Good 15.56% Good | 15.67%Good 15.67% Good | 0.68Good 0.7 Good | 94.55%Excellent 94.55% Excellent | 17.00%Excellent 17.00% Excellent | 0.74% |
52.8/100 | ₹516.15₹516 | ₹7381.56₹7381.56 | 11.61Average 11.6 Average | 7.08%Poor 7.08% Poor | 9.57%Poor 9.57% Poor | 0.00Excellent 0.0 Excellent | 3.30%Average 3.30% Average | 8.86%Good 8.86% Good | 3.58% | |
Ghcl LtdGhcl Ltd... GHCL • 500171 | 40.4/100 | ₹463.10₹463 | ₹5520.31₹5520.31 | 9.69Average 9.7 Average | 18.57%Good 18.57% Good | 24.19%Excellent 24.19% Excellent | 0.03Excellent 0.0 Excellent | 8.63%Good 8.63% Good | -0.75%Poor -0.75% Poor | 2.09% |
Blue Pearl Agriventures LtdBlue Pearl Agri... BPAGRI • 514440 | 19.7/100 | ₹17.52₹18 | ₹5397.73₹5397.73 | 9306.43Average 9306.4 Average | 2.12%Poor 2.12% Poor | 2.57%Poor 2.57% Poor | 0.00Excellent 0.0 Excellent | — — | 173.71%Excellent 173.71% Excellent | 0.00% |
Chemplast Sanmar LtdChemplast Sanma... CHEMPLASTS • 543336 | 24.4/100 | ₹222.23₹222 | ₹4503.74₹4503.74 | — — | -5.93%Poor -5.93% Poor | 1.83%Poor 1.83% Poor | 0.97Good 1.0 Good | — — | 28.15%Excellent 28.15% Excellent | 0.00% |
Tanfac Industries LtdTanfac Industri... TANFACIND • 506854 | 68.7/100 | ₹1971.70₹1972 | ₹4106.65₹4106.65 | 43.66Average 43.7 Average | 32.05%Excellent 32.05% Excellent | 41.76%Excellent 41.76% Excellent | 0.09Excellent 0.1 Excellent | 38.64%Excellent 38.64% Excellent | 27.58%Excellent 27.58% Excellent | 0.22% |
Gujarat Alkalies and Chemicals LtdGujarat Alkalie... GUJALKALI • 530001 | 28/100 | ₹687.35₹687 | ₹3866.17₹3866.17 | 25774.49Average 25774.5 Average | -1.13%Poor -1.13% Poor | -0.34%Poor -0.34% Poor | 0.11Excellent 0.1 Excellent | — — | 8.37%Good 8.37% Good | 3.01% |
Grauer & Weil India LtdGrauer & Weil I... GRAUWEIL • 505710 | 59.7/100 | ₹72.27₹72 | ₹3614.14₹3614.14 | 23.93Average 23.9 Average | 17.58%Good 17.58% Good | 23.34%Excellent 23.34% Excellent | 0.01Excellent 0.0 Excellent | 17.17%Excellent 17.17% Excellent | 12.90%Good 12.90% Good | 0.63% |
Top Commodity Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- SRF Ltd share price86606.52 Cr
- Tata Chemicals Ltd share price20261.08 Cr
- Deepak Fertilisers and Petrochemicals Corporation Ltd share price17120.52 Cr
- Gujarat Narmada Valley Fertilizers & Chemicals Ltd share price7381.56 Cr
- Ghcl Ltd share price5520.31 Cr
Kobo Biotech Ltd Quarterly Performance
Latest quarterly metrics for KOBO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-8.13%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
12.21%
Compounded annual net profit growth over 5 years
Kobo Biotech Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for KOBO — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Kobo Biotech Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Kobo Biotech Ltd (KOBO) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Kobo Biotech Ltd
About KOBO (Kobo Biotech Ltd)
Kobo Biotech Ltd is a dynamic force in the commodity chemicals sector, focusing on the innovative development and production of essential chemical building blocks. Positioned as a ...reliable partner for diverse industries, KOBO is committed to delivering high-quality chemical solutions that underpin various manufacturing processes. Through advanced research and development, KOBO ensures that its products meet the stringent standards required for a wide array of applications, from industrial manufacturing and agriculture to water treatment and specialized chemical formulations. KOBO is dedicated to providing cost-effective solutions and fostering strong, collaborative relationships with its clientele. Its commitment to sustainability and environmental stewardship is a core value, ensuring that its chemical products are produced in an eco-friendly manner. Leveraging cutting-edge technology and a team of skilled professionals, KOBO is capable of delivering customized chemical solutions tailored to the specific needs of its customers. Their state-of-the-art manufacturing facilities are designed for optimal efficiency and flexibility, enabling them to respond swiftly to changing market demands and maintain a competitive edge. KOBO continuously invests in research and development to identify new opportunities and create innovative chemical products that drive progress across industries. Their customer-centric approach involves close collaboration with clients, providing technical expertise and ensuring seamless integration of their chemical products into existing processes. KOBO's comprehensive portfolio of commodity chemicals caters to a broad spectrum of industries, providing essential components for a wide range of applications. From basic chemicals utilized in the production of plastics and textiles to specialty chemicals that enhance the performance of agricultural products and water treatment systems, KOBO delivers solutions that drive efficiency and innovation. With a strong focus on quality control and regulatory compliance, KOBO ensures that its products meet the highest standards of purity and safety. By prioritizing customer satisfaction and building long-term partnerships, KOBO aims to be a leading provider of commodity chemicals, contributing to the growth and success of its clients across diverse sectors.
Company Details
Key Leadership
Corporate Events
Latest News
KOBO Share Price: Frequently Asked Questions
What is the current share price of Kobo Biotech Ltd?
Kobo Biotech Ltd (KOBO) trades at ₹4.33 on NSE and BSE. Market cap ₹6.39 (Cr). Educational data only.
What is the P/E ratio of Kobo Biotech Ltd?
Kobo Biotech Ltd has a P/E of N/Ax vs industry average 20.98x.
What is the Bull Run score for Kobo Biotech Ltd?
Kobo Biotech Ltd has a Bull Run score of 20.3/100 based on 25+ financial parameters.
Does Kobo Biotech Ltd pay dividends?
Kobo Biotech Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Kobo Biotech Ltd?
Kobo Biotech Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Kobo Biotech Ltd?
Kobo Biotech Ltd has debt-to-equity of N/A.
Is Kobo Biotech Ltd a good investment?
Bull Run gives Kobo Biotech Ltd a score of 20.3/100. This is not investment advice — consult a SEBI-registered advisor.